By Ahmed AbouleneinWASHINGTON, Aug 11 (Reuters) - The Trump administration finalized a rule on Tuesday barring two major federal health programs from funding puberty blockers, hormone therapy and surgeries to treat gender dysphoria in minors, reshaping access for low-income youth nationwide. The rule, scheduled for publication on ‌Thursday and effective in October, cuts off funding under Medicaid and the Children's Health Insurance Program, or CHIP, which together cover 35.5 million U.S. ‌children. The rule does not ban the procedures but removes the federal support that makes them accessible to millions of low-income children, shifting the burden to states, families and private insurance. The American Academy of Pediatrics and the American Medical Association say such decisions should rest with children, parents and healthcare professionals. The administration has moved to bar transgender people from the ​military, block them from listing their gender identity on passports, and restrict ‌federal workers' bathroom use.